跳至主要内容
临床试验/IRCT20210711051839N1
IRCT20210711051839N1已完成3 期

The effect of pentoxifylline on the incidence rate of acute respiratory distress syndrome (ARDS) in trauma patients

Mashhad University of Medical Sciences0 个研究点目标入组 62 人开始时间: 待定最近更新:

试验速览

阶段
3 期
状态
已完成
入组人数
62

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
20 years 至 40 years(—)
性别
All

入选标准

  • Age between 18 and 65 years
  • Trauma patients at risk for ARDS who have lips=4 based on lung injury prediction score (lips)

排除标准

  • Not having written informed consent.
  • Patients with adrenal insufficiency.
  • Patients with inflammation of the blood vessels.
  • Patients with intolerance to methylxanthine and pentoxifylline.
  • Patients who can not be prescribed the drug orally.
  • Occurrence of possible drug-related side effects if dangerous or intolerable to the patient.

研究者

相似试验